Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Bio-Path Holdings, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 14 | +2 |
| Shares | 142.6K | 2.38K | 59.0K | −81.2K (−57.9%) |
| Value | $285.1K | $4.76K | $53.5K | −$226.8K (−80.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Bio-Path Holdings, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 12,325 | $11.0K | 0.00% |
| Citadel Advisors LLC | 10,917 | $9.93K | 0.00% |
| BlackRock, Inc. | 2,381 | $2.17K | 0.00% |
| EverSource Wealth Advisors, LLC | 10 | $9 | 0.00% |
| Danske Bank A/S | 2 | $2 | 0.00% |
Sold out (3)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Armistice Capital, LLC | 97,000 | $194.0K |
| HRT Financial LP | 14,085 | $28.0K |
| Qube Research & Technologies Ltd | 100 | $200 |
Not filed for Q3 2024 yet (1)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,381 | $4.76K |